Overview

Thoracic Paravertebral Blocks Using a Combination of Ropivacaine and Dexmedetomidine

Status:
Unknown status
Trial end date:
2019-03-30
Target enrollment:
Participant gender:
Summary
The investigators designed a study to assess whether thoracic paravertebral blocks using a combination of ropivacaine and dexmedetomidine prolong nerve block duration.
Phase:
Phase 4
Details
Lead Sponsor:
China Medical University, China
Treatments:
Dexmedetomidine
Ropivacaine